يعرض 1 - 10 نتائج من 43 نتيجة بحث عن '"Ben C. Valdez"', وقت الاستعلام: 1.01s تنقيح النتائج
  1. 1
    دورية أكاديمية
    P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES

    المؤلفون: Uday R. Popat, Konstantinos Lontos, Roland Bassett, Jitesh Kawedia, Ben C. Valdez, Alison Gulbis, Amin M. Alousi, Gheath Al-Atrash, Qaiser Bashir, Chitra M. Hosing, Jin S. Im, Partow Kebriaei, Issa Khouri, David Marin, Rohtesh S. Mehta, Yago Nieto, Betul Oran, Amanda Olson, Muzaffar H. Qazilbash, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Tapan Kadia, Naval Daver, Nicholas Short, Katayoun Rezvani, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson

    المصدر: HemaSphere, Vol 7, p e069901e (2023)

    مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

    وصف الملف: electronic resource

    Relation: http://journals.lww.com/10.1097/01.HS9.0000971968.06990.1e; https://doaj.org/toc/2572-9241

    URL الوصول: https://doaj.org/article/23db3b9de20147329d768cec42074ac7

    View record in Lippincott, Williams & Wilkins View record at Wiley Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study

    المؤلفون: Uday R. Popat, Borje S Andersson, Roland Bassett, Jitesh Kawedia, Ben C. Valdez, Amin M. Alousi, Gheath Al-Atrash, Qaiser Bashir, Chitra M. Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Betul Oran, Amanda Olson, Muzaffar H. Qazilbash, Samer A. Srour, Elizabeth J. Shpall, Richard E. Champlin, Rohtesh S. Mehta

    المصدر: Haematologica, Vol 107, Iss 10 (2022)

    مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

    وصف الملف: electronic resource

    Relation: https://haematologica.org/article/view/10696; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721

    URL الوصول: https://doaj.org/article/3888712a686543238bcfd5b05ee90de1

    Full Text Finder
    أضف إلى المفضلة
  3. 3
    Safety and Efficacy of a New High-Dose Chemotherapy (HDC) Regimen of Panobinostat (Pano), Gemcitabine (Gem), Busulfan (Bu) and Melphalan (Mel) (Pano/GBM) with Autologous Stem Cell Transplant (ASCT) for Patients (pts) with High-Risk (HR) or Refractory/Relapsed (R/R) Myeloma (MM) – Matched Pair Comparisons with a Concurrent Control Cohort

    المؤلفون: Yago Nieto, Zixi Yang, Ben C. Valdez, Suprateek Kundu, Roland Bassett, Melissa Barnett, Qaiser Bashir, Jeremy Ramdial, Neeraj Y. Saini, Samer A. Srour, Jin Seon Im, Partow Kebriaei, Uday R. Popat, Alison M. Gulbis, Rita Cool, Terri Lynn Shigle, Whitney Dale Wallis, Jason Yeh, Ruby Delgado, Sofia Qureshi, Hans C. Lee, Elisabet Manasanch, Robert Z. Orlowski, Sheeba K. Thomas, Elizabeth J. Shpall, Borje S. Andersson, Muzaffar H. Qazilbash

    المصدر: Transplantation and Cellular Therapy. 29:S31-S32

    مصطلحات موضوعية: Transplantation, Molecular Medicine, Immunology and Allergy, Cell Biology, Hematology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::80858ea262e69e657d061b4d73be9af6
    https://doi.org/10.1016/s2666-6367(23)00107-0

    Full Text via ClinicalKey
    أضف إلى المفضلة
  4. 4
    Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome

    المؤلفون: Betul Oran, Ben C. Valdez, Partow Kebriaei, Rohtesh S. Mehta, Katy Rezvani, David Marin, Julianne Chen, Elizabeth J. Shpall, Amin M. Alousi, Uday R. Popat, Richard E. Champlin, Qaiser Bashir, Rima M. Saliba, Amanda Olson, Stefan O. Ciurea, Borje S. Andersson, Chitra Hosing

    المصدر: Cancer. 127:1598-1605

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Transplantation Conditioning, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Busulfan, Aged, business.industry, Hazard ratio, Area under the curve, Myeloid leukemia, Myeloablative Agonists, Survival Analysis, Fludarabine, Leukemia, Myeloid, Acute, Regimen, Treatment Outcome, Oncology, Myelodysplastic Syndromes, 030220 oncology & carcinogenesis, Methotrexate, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d14f080997280c7ce17a0070c92a006
    https://doi.org/10.1002/cncr.33383

    View record at Wiley
    أضف إلى المفضلة
  5. 5
    Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial

    المؤلفون: Qaiser Bashir, Hans C Lee, Betul Oran, Richard E. Champlin, Loretta A. Williams, Simrit Parmar, Chitra Hosing, Muzaffar H. Qazilbash, Partow Kebriaei, Jitesh D. Kawedia, Robert Z. Orlowski, Sheeba K. Thomas, Patricia S. Fox, Elisabet E. Manasanch, Donna M Weber, Borje S. Andersson, Gabriela Rondon, Yago Nieto, Pei Lin, Peter F. Thall, Ruby Delgado, U. Popat, Ben C. Valdez, Nina Shah, Krina K. Patel, Stefan O. Ciurea, Denái R. Milton

    المصدر: The Lancet Haematology. 6:e266-e275

    مصطلحات موضوعية: Melphalan, medicine.medical_specialty, Urology, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, immune system diseases, law, hemic and lymphatic diseases, medicine, Mucositis, neoplasms, Multiple myeloma, business.industry, Hazard ratio, Area under the curve, Hematology, medicine.disease, Transplantation, surgical procedures, operative, 030220 oncology & carcinogenesis, business, Busulfan, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9048850ac063221a0cb7d2e49bcf3566
    https://doi.org/10.1016/s2352-3026(19)30023-7

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  6. 6
    Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial

    المؤلفون: Stefan O. Ciurea, Roy B. Jones, Sergej Konoplev, Ben C. Valdez, Amanda Olson, Muzaffar H. Qazilbash, Amin M. Alousi, Sairah Ahmed, Issa F. Khouri, Richard E. Champlin, Yago Nieto, Nina Shah, Partow Kebriaei, Man Yin C. Poon, Qaiser Bashir, Katyoun Rezvani, Simrit Parmar, Betul Oran, Uday R. Popat, Elizabeth J. Shpall, Roland L. Bassett, Stella K. Kim, Chitra Hosing, Borje S. Andersson

    المصدر: Transplantation and Cellular Therapy. 27:430.e1-430.e7

    مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, Eltrombopag, Placebo-controlled study, Phases of clinical research, Hematopoietic stem cell transplantation, Placebo, Benzoates, Gastroenterology, chemistry.chemical_compound, Internal medicine, medicine, Humans, Immunology and Allergy, Platelet, Thrombopoietin receptor, Transplantation, business.industry, Cell Biology, Hematology, Thrombocytopenia, Hydrazines, chemistry, Absolute neutrophil count, Pyrazoles, Molecular Medicine, Neoplasm Recurrence, Local, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c99aa2bf5793883a85b38c9654160a
    https://doi.org/10.1016/j.jtct.2021.02.004

    Full Text via ClinicalKey
    أضف إلى المفضلة
  7. 7
    Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results

    المؤلفون: Celina Ledesma, Roy B. Jones, Partow Kebriaei, Chitra Hosing, Issa F. Khouri, Borje S. Andersson, Krina K. Patel, Sairah Ahmed, Stefan O. Ciurea, Qaiser Bashir, Amin M. Alousi, Genevieve Lyons, Betul Oran, Uday R. Popat, Amanda Olson, Elizabeth J. Shpall, Roland L. Bassett, Gabriela Rondon, Nina Shah, David Marin, Muzaffar H. Qazilbash, Richard E. Champlin, Ben C. Valdez, Yago Nieto, Katayoun Rezvani

    المصدر: Biology of Blood and Marrow Transplantation. 23:285-292

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Transplantation Conditioning, Adolescent, medicine.medical_treatment, Graft vs Host Disease, Hematopoietic stem cell transplantation, Gastroenterology, Disease-Free Survival, Article, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Adenine nucleotide, Internal medicine, medicine, Humans, Clofarabine, Busulfan, Transplantation, Dose-Response Relationship, Drug, Adenine Nucleotides, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Total body irradiation, Allografts, Minimal residual disease, Surgery, Regimen, 030220 oncology & carcinogenesis, Female, Arabinonucleosides, business, Whole-Body Irradiation, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b29f4e1e5e05f6dbb4afad24a72242d
    https://doi.org/10.1016/j.bbmt.2016.11.001

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  8. 8
    Conditioning with Busulfan Plus Melphalan (Bu-Mel) Results in More Prolonged Progression-Free Survival (PFS) Versus Melphalan (Mel) Alone before Autologous Stem Cell Transplantation (auto-HCT) in Patients with High-Risk Multiple Myeloma (MM): Long-Term Results of a Randomized, Phase 3 Trial

    المؤلفون: Chitra Hosing, Simrit Parmar, Donna M. Weber, Partow Kebriaei, Sheeba K. Thomas, Uday R. Popat, Elisabet E. Manasanch, Krina K. Patel, Pei Lin, Stefan O. Ciurea, Jitesh D. Kawedia, Denái R. Milton, Peter F. Thall, Borje S. Andersson, Robert Z. Orlowski, Gabriela Rondon, Betul Oran, Ben C. Valdez, Hans C. Lee, Elizabeth J. Shpall, Muzaffar H. Qazilbash, Richard E. Champlin, Qaiser Bashir, Yago Nieto, Loretta A. Williams, Ruby Delgado

    المصدر: Biology of Blood and Marrow Transplantation. 26:S241-S242

    مصطلحات موضوعية: Melphalan, Transplantation, medicine.medical_specialty, Neutrophil Engraftment, Platelet Engraftment, business.industry, Urology, Hematology, medicine.disease, carbohydrates (lipids), Autologous stem-cell transplantation, Maintenance therapy, hemic and lymphatic diseases, medicine, Progression-free survival, business, neoplasms, Busulfan, Multiple myeloma, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a8e14764986fcd22baae98ef1d4e988f
    https://doi.org/10.1016/j.bbmt.2019.12.488

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
  9. 9
    Fludarabine with pharmacokinetically-guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

    المؤلفون: Roy B. Jones, Partow Kebriaei, Laura L. Worth, Amin M. Alousi, Charles Martinez, Simrit Parmar, Timothy Madden, Alan L. Myers, Elizabeth J. Shpall, J. Chen, Jitesh D. Kawedia, Diem T. Chu, Denái R. Milton, Ben C. Valdez, Marcelo Fernandez-Vina, Alison M. Gulbis, Q H Meng, Borje S. Andersson, Gheath Alatrash, Richard E. Champlin, Peter F. Thall, Uday R. Popat, Gabriella Rondon, Yago Nieto, M. de Lima

    المصدر: Bone marrow transplantation

    مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Transplantation Conditioning, Graft vs Host Disease, Article, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Transplantation, Homologous, Dosing, Busulfan, Survival analysis, Transplantation, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, medicine.disease, Survival Analysis, 3. Good health, Surgery, Fludarabine, Regimen, Leukemia, Myeloid, Acute, Graft-versus-host disease, Treatment Outcome, 030220 oncology & carcinogenesis, Myelodysplastic Syndromes, Toxicity, Female, Drug Monitoring, business, Vidarabine, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acbdc1320f1f2c82e6d9892bed0bf36c
    http://europepmc.org/articles/PMC5382042

    Find this article in full text from Springer Verlag. Find this article in full text from ProQuest
    أضف إلى المفضلة
  10. 10
    Romidepsin (Rom) in Combination with Fludarabine (Flu) and Busulfan (Bu) Conditioning Followed by Rom Maintenance in Patients with T-Cell Malignancies Receiving Allogeneic Stem Cell Transplant (Allo-SCT): Early Results of a Phase I/II Trial

    المؤلفون: Ben C. Valdez, Uday R. Popat, Borje S. Andersson, Richard E. Champlin, Jonathan E. Brammer, Chitra Hosing

    المصدر: Biology of Blood and Marrow Transplantation. 24:S262-S263

    مصطلحات موضوعية: Oncology, Transplantation, medicine.medical_specialty, business.industry, T cell, Hematology, Allo sct, Romidepsin, Fludarabine, medicine.anatomical_structure, Early results, Internal medicine, Medicine, In patient, Stem cell, business, Busulfan, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5d1a49b3d725989011e8f7a5e9550464
    https://doi.org/10.1016/j.bbmt.2017.12.241

    View record from ScienceDirect Full Text via ClinicalKey
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء